| BACKGROUND
In2012,theInternationalFederation ofObstetrics andGynecology (FIGO)producedachartdetailingrecommendeddosagesofmisoprostolwhenusedalone,foravarietyofgynecologicandobstetricindications. In light of new evidence [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] and through expert deliberation, this chart has now been revised and expanded (Fig.1) . Some areas wereparticularlychallengingtodevelopgiventhelimited,low-quality, or inconsistent evidence. The present commentary is intended to explainsomeofthechangesanddecisionsmade.
| GENERAL CHANGES
The layout is now categorized vertically by gestation and horizontally by indication. Gestation is labelled and referred to as the number of weeks of gestation (<13weeks, 13-26weeks, and >26weeks), with the final column being for postpartum use. However, in the case of incompleteabortionunder13weeks,andinevitableabortionbetween 13-26 weeks, women should be treated on the basis of their uterine size rather than last menstrual period dating. Recommendations have beenaddedforinevitableabortionandcervicalpreparationbetween13 and26weeks,andforterminationofpregnancyatmorethan26weeks. Therefore,without evidence to support a safe regimen,we do not provide one, other than to recommend following local protocol in these cases. and evidencehassupportedthesafetyofthe"higher"dosesforwomen.
| NUMBER OF DOSES

| MISOPROSTOL USE IN PREGNANCIES WITH PREVIOUS CESAREAN OR TRANSMURAL UTERINE SCAR
| MANAGEMENT OF PREGNANCY TERMINATION AND FETAL DEATH OVER 2WEEKS' GESTATION
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Recommendationsinthechartwerecompiledwiththisinmind,while alsoacknowledgingthatitispossiblethatarangeofdosagescouldbe effectiveandsafe.
| RETAINED PLACENTA
Therehavebeentwostudiesoftheuseofmisoprostolforthetreatmentofretainedplacentafollowinglivebirth,neitherofwhichshow any benefit over placebo.
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We therefore do not recommend misoprostolforretainedplacentainlatepregnancy.
| SECONDARY PREVENTION OF POSTPARTUM HEMORRHAGE FOR COMMUNITY-BASED PROGRAMS
Secondary prevention is a community-based strategy that has been shown to be a comparable alternative to a universal prophylaxis approachintwolargecommunitytrials(oneinpress).
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Ratherthan medicatingallwomenduringthethirdstageoflaborwithaprophylacticdose,aregimenof800μg sublingual misoprostol (the same as for treatment) can be used to treat only women with higher-thanaveragebleeding(e.g.approximately350mLormore).Althoughthere is limitedpublisheddata,itwasagreedthatsecondarypreventionof PPHisastrongalternativeapproachtouniversalprophylaxis,because it involves medicating far fewer women (5%-10% vs 100%), thus causingfeweradverseeffectsandreducingcosts.
| CONCLUSION
The FIGO Misoprostol-only Recommended Regimens 2017 chart (Fig.1) Misoprostolisanimportantmedicineand,althoughitshouldnot be used in preference over oxytocin for postpartum hemorrhage, or instead of mifepristone plus misoprostol for pregnancy termination, it could be the only medicine available in some circumstances, which iswhy FIGO believes this "misoprostol-only" chart is needed. 
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